Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion (Q33415207)

26 July 2017

title

Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion (English)

1 reference

26 July 2017

1 reference

Jeremy Ryan A Peña

1

1 reference

26 July 2017

Susan L Saidman

2

1 reference

26 July 2017

Timothy C Girouard

3

1 reference

26 July 2017

Erin Meister

4

1 reference

26 July 2017

Walter H Dzik

5

1 reference

26 July 2017

Robert S Makar

6

1 reference

26 July 2017

publication date

19 June 2014

1 reference

American Journal of Hematology

26 July 2017

published in

1 reference

26 July 2017

volume

89

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

E133-7

1 reference

Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Calculated PRA (CPRA): the new measure of sensitization for transplant candidates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

New paradigms in the management of alloimmune refractoriness to platelet transfusions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Refractoriness to platelet transfusion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4416418

Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.

21 June 2018

1 reference

Prevalence of HLA antibodies in transfused patients with and without red cell antibodies

21 January 2018

1 reference

Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.

21 January 2018

1 reference

Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma

21 January 2018

1 reference

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens

21 January 2018

1 reference

12 December 2020

Histocompatibility antigens of human plasma. Localization to the HLD-3 lipoprotein fraction

1 reference

12 December 2020

Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets

1 reference

12 December 2020

A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants

1 reference

12 December 2020

Identifiers

DOI

10.1002/AJH.23757

1 reference

26 July 2017

1 reference

26 July 2017

1 reference